{"id":"https://genegraph.clinicalgenome.org/r/1c674a1a-a674-40cf-99b9-5773f878e1aev1.0","type":"EvidenceStrengthAssertion","dc:description":"*AP4S1* loss-of-function variants were first reported in relation to autosomal recessive Adaptor Protein 4 (AP-4) deficiency syndrome in 2011 (PMID: 21620353). AP-4 deficiency results in severe early-onset developmental delay with motor and speech delay, intellectual disability, hypotonia in infancy followed by spastic paraplegia and later tetraplegia, microcephaly, and seizures (PMID: 32979048). At least 23 individuals from 16 families with biallelic *AP4S1* nonsense, frameshift, splicing and missense variants leading to loss of protein function have been reported (PMIDs: 21620353, 25552650, 32979048). \n\nThe gene-disease association is further supported by biochemical and functional evidence demonstrating loss of AP-4 complex function and impaired protein localization in fibroblasts from patients with biallelic *AP4S1* loss-of-function variants (PMID: 25552650). Loss of *AP4S1* in zebrafish also results in reduced head size, altered CNS development, locomotor deficits, and abnormal neuronal excitability (PMID: 32216065). \n\nIn summary, there is definitive evidence supporting the relationship between *AP4S1* and autosomal recessive AP-4 deficiency syndrome. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 25, 2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1c674a1a-a674-40cf-99b9-5773f878e1ae","GCISnapshot":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2023-04-25T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2023-06-02T19:07:18.917Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9db94af1-75d7-4e37-b48a-d302004fb2ee_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21620353","rdfs:label":"MR061","family":{"id":"https://genegraph.clinicalgenome.org/r/9db94af1-75d7-4e37-b48a-d302004fb2ee","type":"Family","rdfs:label":"MR061","member":{"id":"https://genegraph.clinicalgenome.org/r/2a1c608f-3e09-4f38-aa7a-26afb4f7a4b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21620353","rdfs:label":"V-14","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5699eb42-e7ff-42d6-8938-b6b11b34657a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.124C>T (p.Arg42Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342743"}},"detectionMethod":"Autozygosity mapping and either Sanger sequencing of candidate genes or next-generation exome sequencing","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0001263","obo:HP_0001258","obo:HP_0001270","obo:HP_0000750"],"secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b56e89b0-ced4-4c63-ba1c-c030f5297aa5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21620353","allele":{"id":"https://genegraph.clinicalgenome.org/r/5699eb42-e7ff-42d6-8938-b6b11b34657a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000750","obo:HP_0001270","obo:HP_0001258","obo:HP_0001263"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2a1c608f-3e09-4f38-aa7a-26afb4f7a4b1"}},{"id":"https://genegraph.clinicalgenome.org/r/b93fd2f6-f32b-4bef-8273-5ebed83984ae_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25552650","rdfs:label":"Hardies-2015","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/b93fd2f6-f32b-4bef-8273-5ebed83984ae","type":"Family","rdfs:label":"Hardies-2015","member":{"id":"https://genegraph.clinicalgenome.org/r/95f760e1-62f7-4675-9fae-9d7b10cc74c8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25552650","rdfs:label":"Hardies1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/4c942361-e0ae-4d9e-82e7-e22521c9d7de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.289C>T (p.Arg97Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7144219"}},{"id":"https://genegraph.clinicalgenome.org/r/357d52a7-dd4a-4735-8d1d-629a1ff64d7e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.31066337_31066340del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7144150"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001270","obo:HP_0001258","obo:HP_0001250","obo:HP_0000252","obo:HP_0001263"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b7279ecc-fe19-4a3d-8773-6ef4c6f5e1a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25552650","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c942361-e0ae-4d9e-82e7-e22521c9d7de"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/c772440d-44c2-41c9-ace8-74e25b3abada_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25552650","allele":{"id":"https://genegraph.clinicalgenome.org/r/357d52a7-dd4a-4735-8d1d-629a1ff64d7e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001270","obo:HP_0001263","obo:HP_0000252","obo:HP_0001258","obo:HP_0001250"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/95f760e1-62f7-4675-9fae-9d7b10cc74c8"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2a1c608f-3e09-4f38-aa7a-26afb4f7a4b1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b56e89b0-ced4-4c63-ba1c-c030f5297aa5","type":"EvidenceLine","dc:description":"2 points (total) were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V9) for each case is too high and allows for too few (only 4) cases to reach a definitive classification for AR conditions. Awarding 2 points per case and\nrequiring more cases to reach a definitive classification is recommended by the ID/autism expert panel.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b56e89b0-ced4-4c63-ba1c-c030f5297aa5_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2a1c608f-3e09-4f38-aa7a-26afb4f7a4b1"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7c79a13c-0b08-4940-be99-1186ff2de25f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eca5a71f-1089-4072-af2e-1e29f5fbca18","type":"EvidenceLine","dc:description":"2 points (total) were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V9) for each case is too high and allows for too few (only 4) cases to reach a definitive classification for AR conditions. Awarding 2 points per case and requiring more cases to reach a definitive classification is recommended by the ID/autism expert panel.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eca5a71f-1089-4072-af2e-1e29f5fbca18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7bd9a2-5d4b-4ed7-8aab-eb7bc8db8a75","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.49dup (p.Ser17PhefsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573149824"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dcc9b80d-b80e-44dd-9cab-78fbdfb3835c","type":"EvidenceLine","dc:description":"2 points (total) were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V9) for each case is too high and allows for too few (only 4) cases to reach a definitive classification for AR conditions. Awarding 2 points per case and requiring more cases to reach a definitive classification is recommended by the ID/autism expert panel.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcc9b80d-b80e-44dd-9cab-78fbdfb3835c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/04238297-24e6-4261-b385-02df01ee6739","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.239_240insG (p.Ile80MetfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573149827"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7c79a13c-0b08-4940-be99-1186ff2de25f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"084","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/04238297-24e6-4261-b385-02df01ee6739"},{"id":"https://genegraph.clinicalgenome.org/r/1e7bd9a2-5d4b-4ed7-8aab-eb7bc8db8a75"}],"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000750","obo:HP_0001270","obo:HP_0001263","obo:HP_0001258"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/dcc9b80d-b80e-44dd-9cab-78fbdfb3835c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/eca5a71f-1089-4072-af2e-1e29f5fbca18_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/73a2d869-f19b-41ba-a973-360f7f3c0e0f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/882a0de5-ba92-471e-bd63-9576b236414f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/882a0de5-ba92-471e-bd63-9576b236414f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c942361-e0ae-4d9e-82e7-e22521c9d7de"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/73e32bd9-8ea0-4060-ae3e-db29cf3d360d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73e32bd9-8ea0-4060-ae3e-db29cf3d360d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/357d52a7-dd4a-4735-8d1d-629a1ff64d7e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/73a2d869-f19b-41ba-a973-360f7f3c0e0f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"098","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/4c942361-e0ae-4d9e-82e7-e22521c9d7de"},{"id":"https://genegraph.clinicalgenome.org/r/357d52a7-dd4a-4735-8d1d-629a1ff64d7e"}],"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000750","obo:HP_0000252","obo:HP_0001250","obo:HP_0001270","obo:HP_0001258","obo:HP_0001263"],"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/73e32bd9-8ea0-4060-ae3e-db29cf3d360d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/882a0de5-ba92-471e-bd63-9576b236414f_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/95f760e1-62f7-4675-9fae-9d7b10cc74c8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c772440d-44c2-41c9-ace8-74e25b3abada","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c772440d-44c2-41c9-ace8-74e25b3abada_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b7279ecc-fe19-4a3d-8773-6ef4c6f5e1a3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7279ecc-fe19-4a3d-8773-6ef4c6f5e1a3_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/95f760e1-62f7-4675-9fae-9d7b10cc74c8"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/3c902239-50a0-4e9b-828e-c31541414bda_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/673d6902-d461-44f2-b0fe-5680fbcbda56","type":"EvidenceLine","dc:description":"2 points (total) were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V9) for each case is too high and allows for too few (only 4) cases to reach a definitive classification for AR conditions. Awarding 2 points per case and requiring more cases to reach a definitive classification is recommended by the ID/autism expert panel.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/673d6902-d461-44f2-b0fe-5680fbcbda56_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd62034a-dcfe-49c8-833d-7b84e436ec7a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.43C>T (p.Arg15Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7144127"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3c902239-50a0-4e9b-828e-c31541414bda","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"059","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fd62034a-dcfe-49c8-833d-7b84e436ec7a"},"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001258","obo:HP_0000750","obo:HP_0001270","obo:HP_0001263","obo:HP_0000252","obo:HP_0001250"],"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/673d6902-d461-44f2-b0fe-5680fbcbda56_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3c5a9b78-bb63-438c-a9a2-32b839550b6d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2561ec2e-71be-4922-a8b9-a8b4c820e91a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2561ec2e-71be-4922-a8b9-a8b4c820e91a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9eff467-fcd0-45cf-bb98-26d3a7177010","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.17T>C (p.Leu6Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389358554"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/50d5c3c2-85b2-4b84-a1d5-2470b52bda21","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50d5c3c2-85b2-4b84-a1d5-2470b52bda21_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/911fbf52-ca2f-4e4e-89bd-4b122a7eb713","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.229G>T (p.Glu77Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389360325"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3c5a9b78-bb63-438c-a9a2-32b839550b6d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"065","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/911fbf52-ca2f-4e4e-89bd-4b122a7eb713"},{"id":"https://genegraph.clinicalgenome.org/r/e9eff467-fcd0-45cf-bb98-26d3a7177010"}],"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000750","obo:HP_0001263","obo:HP_0001250","obo:HP_0001258","obo:HP_0000252","obo:HP_0001270"],"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2561ec2e-71be-4922-a8b9-a8b4c820e91a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/50d5c3c2-85b2-4b84-a1d5-2470b52bda21_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/9f482d51-26e9-4ff2-b732-8d9f8cb83ee8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c25fcd9-1658-494e-9d48-c9b9a801b95c","type":"EvidenceLine","dc:description":"2 points (total) were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V9) for each case is too high and allows for too few (only 4) cases to reach a definitive classification for AR conditions. Awarding 2 points per case and requiring more cases to reach a definitive classification is recommended by the ID/autism expert panel.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c25fcd9-1658-494e-9d48-c9b9a801b95c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7bd9a2-5d4b-4ed7-8aab-eb7bc8db8a75"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9f482d51-26e9-4ff2-b732-8d9f8cb83ee8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"060","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7bd9a2-5d4b-4ed7-8aab-eb7bc8db8a75"},"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001258","obo:HP_0000750","obo:HP_0001263","obo:HP_0000252","obo:HP_0001270","obo:HP_0001250"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6c25fcd9-1658-494e-9d48-c9b9a801b95c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f74c71f4-27e3-4e4c-a9ec-cb519e2b1449_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd1ffbcd-e3c4-417e-8857-56d6a34904e1","type":"EvidenceLine","dc:description":"2 points (total) were awarded based on the ID/autism expert group’s opinion that awarding 3 points (recommended based on SOP V9) for each case is too high and allows for too few (only 4) cases to reach a definitive classification for AR conditions. Awarding 2 points per case and requiring more cases to reach a definitive classification is recommended by the ID/autism expert panel.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd1ffbcd-e3c4-417e-8857-56d6a34904e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","allele":{"id":"https://genegraph.clinicalgenome.org/r/50e239a5-e503-4e7b-b8b1-cd02670c752d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128126.3(AP4S1):c.294+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10603400"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f74c71f4-27e3-4e4c-a9ec-cb519e2b1449","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"109","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/50e239a5-e503-4e7b-b8b1-cd02670c752d"},"detectionMethod":"Exome sequencing used in most cases, as well as panel testing and Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0000750","obo:HP_0001270","obo:HP_0001263","obo:HP_0001258"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bd1ffbcd-e3c4-417e-8857-56d6a34904e1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8770e146-b95d-4f60-a7b3-565c09f8c8c8","type":"EvidenceLine","dc:description":"Downgraded by 1 point because it is a non-mammalian model organism","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e22553ea-c749-461e-bb05-23d67faac936","type":"Finding","dc:description":"Impaired CNS development, locomotor deficits, and abnormal neuronal excitability seen in AP4E1 knockout zebrafish is relevant to impaired motor development, spastic paraplegia, seizures and developmental delay seen in humans","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32216065","rdfs:label":"Zebrafish-model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ad214ae-3800-4db8-a3bf-6d4ebd17bf11","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01d44260-dbb4-49e9-a202-8794597f110f","type":"FunctionalAlteration","dc:description":"Reduction of all AP4 subunits was observed in patient cells with AP4S1 LoF variants compared to controls, tepsin interaction was also reduced in co-immunoprecipitation assay","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25552650","rdfs:label":"Hardies"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/652e2cbe-22aa-4cd4-ba41-5bacca69af13_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51e0500c-3e30-4c74-bbee-cb66cec500d3","type":"EvidenceLine","dc:description":"The finding that all four AP4 subunits result in a very similar, distinct phenotype is very strong evidence; this also demonstrates biochemical functional evidence of the involvement of AP4S1 in  the AP4 complex","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea420b4d-2ad2-48d9-8482-a83df804423b","type":"Finding","dc:description":"AP4B1, AP4E1 and AP4M1 also encode the three other subunits of the adaptor protein 4 (AP4); loss of any of these subunits results in the same AP4 deficiency clinical phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32979048","rdfs:label":"AP4 Protein Function","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Definitive","sequence":6325,"specifiedBy":"GeneValidityCriteria9","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/vSPjpHAkHhk","type":"GeneValidityProposition","disease":"obo:MONDO_0100176","gene":"hgnc:575","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_652e2cbe-22aa-4cd4-ba41-5bacca69af13-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}